Zogenix, Inc. (ZGNX) PT Lowered to $50 at Needham & Company on FDA Review Extension
Tweet Send to a Friend
Needham & Company analyst Serge Belanger lowered the price target on Zogenix, Inc. (NASDAQ: ZGNX) to $50.00 (from $54.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
